Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas

Cancer Investigation

Volumn 25, Issue 7, 2007, Pages 555-562

  Pistolesi, Sabina ^a   Boldrini, Laura ^a   Gisfredi, Silvia ^a   Ursino, Silvia ^a   Alì, Greta ^a   Nuti, Simona ^a   De Ieso, Katia ^a   Pieracci, Nicola ^a   Parenti, Giuliano ^a   Fontanini, Gabriella ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE   (Italy)

Author keywords

Brain edema; Cyclooxygenase 2; Meningiomas; VEGF

Indexed keywords

CYCLOOXYGENASE 2; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BRAIN EDEMA; CANCER GRADING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA EXTRACTION;

ADULT; AGED; BRAIN EDEMA; CYCLOOXYGENASE 2; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MICROCIRCULATION; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36248930584     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701508280     Document Type: Article

References (57)

1. Perry, A.;, Statford, S.L.; Scheithauer, B.W.; Suman, V.J.; Lohse, C.M.; Wollan, P.C. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients. Cancer 1999, 85, 2046-2056.
2. Watson, M.A.; Gutmann, D.H.; Peterson, K.; Chicoine, M. R.; Kleinschmidt-DeMasters, B.K.; Brown, H.G.; Perry, A. Molecular characterization of human meningiomas by gne expression profilino using high-density oligonucleotide microarrays. AJP 2002, 161, 665-672.
3. Pistolesi, S.; Boldrini, L.; Gisfredi, S.; De Ieso, K.; Camacci T.; Caniglia, M.; Lupi, G.; Leocata, P.; Basolo, F.; Pingitore, R.; Parenti, G.; Fontanini, G. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathology and Applied neurobiology 2004, 30, 118-125.
4. Provias, J.; De Claffey, K. I.; Aguila, L.; Nelson, L.; Feldkamp, M.; Guha, A. Meningiomas: role of vascular endothelial growth factor/vascular permeabilità factor in angiogenesis and peritumoral edema. Neurosurgery 1997, 40, 1016-1026.
5. Pistolesi, S.; Fontanini, G.; Boldrini, L.; Camacci, T.; De Ieso, K.; Lupi, G.; Caniglia, M.; Mariani, G.; Boni, G.; Suriano, S.; Padolecchia, R.; Pingitore, R.; Parenti, G. The role of somatostatin in vasogenic meningioma associated brain edema. Tumori 2003, 89, 136-140.
6. Assimakopoulou, M.; Sotiropoulou-Bonikou, G.; Maraziotis, T.; Papadakis, N.; Varakis I. Microvessel density in brain tumours. Anticancer Res. 1997, 17, 4747-4753.
7. Hanahan, D.; Folkman, J. Patterns and emergine mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353-364.
8. Tsai, J.C.; Hsiao, Y.Y.; Teng, L.J.; Shun, C.T.; Goldman, C.K.; Kao, M.C. Regulation of vascular endothelial growth factor secretion in human menigioma cells. J. Formos. Med. Assoc. 1999, 98, 111-117.
9. Bohuslavizki, K.H.; Brenner, W.; Braunsdorf, W.E.; Behnke, A.; Tinnermayer, S.; Hugo, H.H.; Jahn, N.; Wolf, H.; Sippel, C.; Clausen, M.; Mehdorn, H.M.; Henze, E. Somatostain receptor scintigraphy in the differentil diagnosis of meningioma. Nucl. Med. Commun. 1996, 17, 302-310.
10. Nathoo, N.; Barnett, G.H.; Golubic, M. The eicosanoid cascade: possible role in gliomas and meningiomas. J. Clin. Pathol. 2004, 57, 6-13.
11. Lin, C.C.; Kenyon, L.; Hyslop, T.; Hammond, E.; Andrews, D.W.; Curran, W.J. Jr.; Dicker, A.P. Cyclooxygenase-2 (COX-2) expression in human meningiomas as a function of tumor grade. Am. J. Clin. Oncol. 2003, 26, 98-102.
12. Joki, T.; Heese, O.; Nikas, D.C.; Bello, L.; Zhang, J.; Kraeft, S.K.; Seyfried, N.T.; Abe, T.; Chen, L.B.; Carroll, R.S.; Black, P.M. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res. 2000, 60, 4296-4931.
13. Deininger, M.H.; Meyermann, R.; Trautmann, K.; Morgalla, M.; Duffner, F.; Grote, E.H.; Wickboldt, J.; Schluesener, H.J. Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res. 2000, 885, 111-116.
14. Smith, W.L.; Garavito, M.; DeWitt, D.L. Prostaglandin endoperoxide H synthase (cyclooxygenase)-1 and 2. J. Biol. Chem. 1996, 271, 33157-33160.
15. Pairet, M.; Engelhardt, G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implication. Fundam. Clin. Pharmacol. 1996, 10, 1-17.
16. DuBois, R.N.; Awad, J.; Morrow, J.; Roberts, L.J. II; Bishop, P.R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Investig. 1994, 93, 493-498.
17. Iadecola, C.; Forster, C.; Nogawa, S.; Clark, H.B.; Ross, M.E. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta. Neuropathol. Berl. 1999, 98, 9-14.
18. Ellis, E.F.; Chao, J.; Heizer, M.L. Brain kininogen following experimental brain injury: evidence for a secondary event. J. Neurosurg. 1989, 71, 437-442.
19. Bagetta, G.; Corasaniti, M.T.; Paoletti, A.M.; Berliocchi, L.; Nistico, R;, Giammarioli, A.M.; Malorni, W.; Finazzi-Agro, A. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cycloxygenase type 2 (COX-2). Biochem. Biophys. Res. Commun. 1998, 244, 818-824.
20. Lukiw, W.J.; Bazan, N.G. Cycloxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J. Neurosi. Res. 1997, 50, 937-945.
21. Zimmermann, K.C.; Sarbia, M.; Weber, A.A.; Borchard, F.; Gabbert, H.E.; Schrork, Cycloxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999, 59, 198-204.
22. Molina, M.A.; Sitja, A.; Lemoine, M.G.; Frazier, M.L.; Sinicrope, F.A. Increased Cycloxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal antiinflammatory drugs. Cancer Res. 1999, 59, 4356-4362.
23. Wardlaw, S.A.; March, T.H.; Belinsky, S.A. Cycloxygenase-2 expression is abundante in alveolar type II cells in lung cancersensitive mouse strains and in premalignant lesions. Carcinogenesis (Lond) 2000, 21, 1371-1377.
24. Yip-Schneider, M.T.; Barnard, D.S.; Billings, S.D.; Cheng, L.; Heilman, D.K.; Lin, A.; Marshall, S.J.; Crowell, P.L.; Marshall, M.S.; Sweeney, C.J. Cycloxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (Lond) 2000, 21, 139-136.
25. Yoshimura, R.; Sano, H.; Masuda, C.; Kawamura, M.; Tsubouchi, Y.; Chargui, J.; Yoshimura, N.; Hla, T.; Wada S. Expression of Cycloxygenase-2 in prostate carcinoma. Cancer (Phila) 2000, 89, 589-596.
26. Kargman, S.L.; O'Neill, G.P.; Vickers, P.J.; Evans, J.F.; Mancini, J.A.; Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 1995, 55, 2556-2559.
27. Kutchera, W.; Jones, D.A.; Matsunami, N.; Groden, J.; McIntyre, T.M.; Zimmermann, G.A.; White, R.L.; Prescott, S.M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 1996, 93, 4816-4820.
28. Chan, G.; Boyle, J.O.; Yang, E.K.; Zhang, F.; Sacks, P.G.; Shah, J.P.; Edelstein, D.; Soslow, R.A; Koki, A.T.; Woerner, B.M.; Masferrer, J.L.; Dannenberg, A.J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 1999, 59, 991-994.
29. Hida, T.; Yatabe, Y.; Achiwa, H.; Muramatsu, H.; Kozaki, K.; Nakamura, S.; Ogawa M., Mitsudomi, T.; Sugiura, T.; Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998, 58, 3761-3764.
30. Paoletti, P.; Chiabrando, C.; Gaetani, P.; Castelli, M.G.; Butti, G.; Martelli, L.; Rolli, M. Prostaglandins in human brain tumors. J. Neurosurg. 1989, 33, 65-69.
31. Subbaramaiah, K.; Telang, N.; Ramonetti, J.T.; Araki, R.; De Vito, B.; Weksler, B.B.; Dannenberg, A.J. Transcription of cyclooxygenase-2 is enhanced in trasformed mammary epithelial cells. Cancer Res. 1996, 56, 4424-4429.
32. Shono, T.; Tofilon, P.J.; Bruner, J.M.; Owolabi, O.; Lang, F.F. Cyclooxygenase-2 expression in human gliomas. Prognostic significance and molecular correlation. Cancer Res. 2001, 61, 4375-4381.
33. Eberhart, C.E.; Coffey, R.J.; Radhika, A.; Giardiello, F.M.; Ferrenbach, S.; DuBois R. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107, 1183-1188.
34. Sano, H.; Kawahito, Y.; Wilder, R.L.; Hashiramoto, A.; Mukai, S.; Asai, K.; Kimura, S.; Kato, H.; Kondo, M.T. Transcription of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 1995, 55, 3785-3789.
35. Kune, G.A.; Kune, S.; Watson, L.F. Colorectal cancer risk, chronic illness, operations and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988, 48, 4399-4404.
36. Thun, M.J.; Namboodiri, M.M.; Heat, C.W. Jr. Aspirin use and reduced risk of fatal colorectal cancer. N. Engl. J. Med. 1991, 325, 1593-1596.
37. Jacoby, R.F.; Seibert, K.; Cole, C.E.; Kelloff, G.; Lubet, R.A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res. 2000, 60, 5040-5044.
38. Tsujii, M.; Kawano, S.; Tsujii, S.; Sawaoka, H.; Hori, M.; DuBois, R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93, 705-716.
39. Liu, X.H.; Kirschenbaum, A.; Yao, S.; Stearns, M.E.; Holland, J.F.; Claffey, K.; Levine A.C. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastasis 1999, 17, 687-694.
40. Liu, X.H.; Kirschenbaum, A.; Yao, S.; Lee, R.; Holland, J.F.; Levine, A.C. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J. Urol. 2000, 164, 820-825.
41. Attiga, F.A.; Fernandez, P.M.; Weeraratna, A.T.; Manyak, M.J.; Paterno, S.R. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res. 2000, 60, 4629-4637.
42. Tsujii, M.; DuBois, R.N. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83, 493-501.
43. Subbaramaiah, K.; Altorki, N.; Chung, W.J.; Mestre, J.R.; Sampat, A.; Dannenberg, A.J. Inhibition of cyclooxygenase-2 gene expression by p53. J. Biol. Chem. 1999, 274, 10911-10915.
44. Lamberts, S.W.J.; Krenning, E.P.; Reubi, J.C. The role of somatostatin and its analogs in the diagnosis and treatment of tumours. Endocr. Rev 1991, 12, 450-482.
45. Bitzer, M.; Wockel, L.; Luft, A.R.; Wakhloo, A.K.; Petersen, D.; Opitz, H.; Sievert, T.; Ernemann, U.; Voigt, K. The importance of pial blood supply to the development of peritumoural brain oedema in meningiomas. J. Neurosurg. 1997, 87, 368-373.
46. Pistolesi, S.; Fontanini, G.; Camacci, T.; De Ieso, K.; Boldrini, L.; Lupi ,G.; Padolecchia, R.; Pingitore, R.; Parenti, G. Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J. Neuro-Oncol. 2002, 60, 159-164.
47. Kleihues, P.; Louis, D.N.; Scheithauer, B.W.; Rorke, L.B.; Reifenberger, G.; Burger, P.C.; Cavanee, W.K. The WHO classification of tumors of the nervous system: J. Neuropathol. Exp. Neurol. 2002, 61, 215-225.
48. Taketo, M.M. Cyclooxigenase-2 inhibitors in tumorigenesis (part I). J. Natl. Cancer Inst. (Bethesda) 1998, 90, 1529-1536.
49. Giardiello, F.M.; Hamilton, S.R.; Krush, A.J.; Piantadosi, S.; Hylind, L.M.; Celano, P.; Booker, S.V.; Robinson, C.R.; Offerhaus, G.J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 1993, 328, 1313-1316.
50. Kune, G.A.; Kune, S.; Watson, L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the melbourne Colorectal Cancer Study. Cancer Res. 1988, 48, 4399-4404.
51. Thun, M.J.; Namboodiri, M.M.; Heath, C.W. Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 1991, 325, 1593-1596.
52. Castelli, M.G.; Chiabrando, C.; Fanelli, R.; Martelli, L.; Butti, G.; Gaetani, P.; Paoletti, P. Increased Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res 1989, 49, 1505-1508.
53. Joki, T.; Heese, O.; Nikas, D.C.; Bello, L.; Zhang, J.; Kraeft, S.K.; Seyfried, N.T.; Abe, T.; Chen, L.B.; Carroll, R.S.; Black, P.M. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res. 2000, 98, 240-244.
54. Matsuo, M.; Yonemitsu, N.; Zaitsu, M.; Ishii, K.; Hamasaki, Y.; Fukuyama, K.; Tabuchi, K.; Miyazaki, S. Expression of prostaglandin H synthase-2 in human brain tumors. Acta. Neuropathol. (Berl) 2001, 102, 181-187.
55. Ragel, B.T.; Jensen, R.L.; Gillespie, D.L.; Prescott, S.M.; Couldwell, W.T. Ubiquitous expression of cyclooxigenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J. Neurosurg. 2005, 103, 508-517.
56. Boldrini, L.; Pistolesi, S.; Gisfredi, S.; Ursino, S.; Lupi, G.; Caniglia, M.; Pingitore, R.; Basolo, F.; Parenti, G.; Fontanini, G. Telomerase in intracranial meningiomas. Int. J. Mol. Med. 2003, 12, 943-947.
57. Khan, R.B.; Krasin, M.J.; Kasow, K.; Leung, W. Cyclooxygenase-2 inhibition to treat radiation-induced brain necrosis and edema. J. Pediatr. Hematol. Oncol. 2004, 26, 253-255.